GLP-1 Injection Costs: Compounded & Branded Pricing Guide

GLP-1 injection costs range from $129 to $600+ monthly depending on medication type, formulation, and dosage strength. Branded options like Ozempic and Wegovy typically cost $900–$1,300 per month without insurance, while compounded alternatives and microdose protocols offer more affordable entry points starting at $129–$229 monthly.

Cost is only one factor in treatment selection. Clinical efficacy, individual metabolic factors, and long-term adherence matter equally. PlexusDx emphasizes transparent pricing paired with precision assessment tools so patients can have informed conversations with providers about which GLP-1 pathway—and price point—aligns with their health goals and budget constraints.

Branded GLP-1 Medications and Their Market Pricing

Branded semaglutide products (Ozempic for diabetes, Wegovy for weight management) are produced by Novo Nordisk and typically cost $900–$1,300 monthly at full retail price. Tirzepatide-based drugs (Mounjaro for diabetes, Zepbound for weight management) by Eli Lilly range $900–$1,400 monthly without insurance coverage.

Insurance coverage varies. Medicare Part D, most private plans, and employer-sponsored benefits may cover these medications with varying copays ($50–$500 per month), but formulary restrictions, prior authorization requirements, and step-therapy protocols often delay patient access or force higher out-of-pocket costs.

Cost Comparison Framework: Branded, Compounded, and Microdose Protocols

Understanding pricing across all GLP-1 options—from branded injectables to compounded formulations and microdose protocols—helps patients evaluate true affordability and accessibility. The framework below illustrates monthly cost ranges, pharmacy sourcing, and clinical considerations for each category.

Why Compounded GLP-1 Medications Cost Less: Understanding the Regulatory Difference

Compounded GLP-1 medications are prepared by licensed 503A pharmacies under state regulation and FDA oversight. They cost substantially less than branded options because they avoid large-scale manufacturing, marketing, and distribution infrastructure that branded pharmaceuticals maintain, passing savings to patients.

Compounded formulations are not FDA-approved drugs in the branded sense but are regulated compounds prepared to USP standards. Patients choosing compounded options should work with qualified healthcare providers to ensure appropriate dosing, monitoring, and safety protocols are followed throughout treatment.

Insurance Coverage, Hidden Costs, and Long-Term Budget Planning

Insurance coverage for GLP-1 medications depends on diagnosis (diabetes vs. weight management), plan type, and medication status on the formulary. Copays range $50–$500 monthly, but deductibles, prior authorization fees, and specialty pharmacy markups can increase total cost. Many patients find out-of-pocket costs exceed insurance savings.

Beyond medication cost, patients should budget for provider visits, baseline labs, periodic monitoring (blood work, vital signs), and potential side effect management. Long-term treatment typically requires ongoing prescriptions; consider asking providers about cost assistance programs, patient savings cards, and whether compounded alternatives might reduce total treatment expense.

Who GLP-1 Treatment Is Appropriate For: Clinical and Safety Considerations

GLP-1 receptor agonists are indicated for type 2 diabetes management and, in certain formulations, for chronic weight management in individuals with obesity or overweight with weight-related conditions. Medical eligibility requires assessment of kidney function, thyroid status, pancreatitis history, and current medications by a qualified healthcare provider.

Contraindications include personal or family history of medullary thyroid carcinoma, history of multiple endocrine neoplasia type 2, severe gastrointestinal disease, and certain pregnancy considerations. Providers should evaluate each patient's metabolic profile, comorbidities, and financial capacity before recommending a specific GLP-1 protocol or price tier.

How PlexusDx Supports a More Personalized Approach

PlexusDx offers compounded semaglutide ($149/mo) and tirzepatide ($249/mo) from licensed 503A pharmacies, positioning affordability alongside clinical care. The Precision Peptide Genetic Test may help provide context regarding individual predispositions in key peptide pathways—including GIPR, GLP1R, FTO, and MC4R variants—which can support a more informed provider conversation about treatment selection.

The Precision Peptide Genetic Test reveals predispositions in peptide genetic pathways relevant to GLP-1 response mechanisms, but genetic testing does not predict exact medication response or guarantee specific outcomes. Results should be interpreted with a qualified healthcare provider to contextualize how individual genetic factors might inform treatment approach and monitoring expectations.

Cost decisions benefit from clinical insight. By understanding your baseline peptide pathway predispositions and discussing them with a provider, you can evaluate whether a microdose protocol ($129/mo), standard-dose compounded semaglutide ($149/mo), or a dual-compound option ($249/mo) aligns with both your health needs and budget. This conversation supports more confident, personalized treatment planning.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

• Glp 1 Cost 2
• Eden Glp 1 Cost Plexusdx
• Glp 1 Cost Plexusdx
• Glp 1 Cost